Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · IEX Real-Time Price · USD
11.40
+0.21 (1.83%)
Jul 22, 2024, 10:14 AM EDT - Market open
Lexeo Therapeutics Analyst Ratings
Total Analysts
7
Consensus Rating
Strong Buy
Price Target
$22.29
Upside
+95.61%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | +93.07% | Jul 16, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $23 | Strong Buy | Maintains | $23 | +101.84% | Jul 15, 2024 |
| Baird | Baird | Buy Initiates $28 | Buy | Initiates | $28 | +145.72% | Jun 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $22 | Strong Buy | Initiates | $22 | +93.07% | Jun 6, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $22 → $24 | Buy | Maintains | $22 → $24 | +110.62% | Mar 12, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Initiates $23 | Strong Buy | Initiates | $23 | +101.84% | Nov 28, 2023 |
| Leerink Partners | Leerink Partners | Buy Initiates $19 | Buy | Initiates | $19 | +66.74% | Nov 28, 2023 |
| RBC Capital | RBC Capital | Buy Initiates $22 | Buy | Initiates | $22 | +93.07% | Nov 28, 2023 |
| Stifel | Stifel | Strong Buy Initiates $20 | Strong Buy | Initiates | $20 | +75.52% | Nov 28, 2023 |
| JP Morgan | JP Morgan | Buy Initiates $20 | Buy | Initiates | $20 | +75.52% | Nov 28, 2023 |